BACKGROUND: FLNC is one of the few genes associated with all types of cardiomyopathies, but it also underlies neuromuscular phenotype. The combination of concomitant neuromuscular and cardiac involvement is not often observed in filaminopathies and the impact of this on the disease prognosis has hitherto not been analyzed. RESULTS: Here we provide a detailed clinical, genetic, and structural prediction analysis of distinct FLNC-associated phenotypes based on twelve pediatric cases. They include early-onset restrictive cardiomyopathy (RCM) in association with congenital myopathy. In all patients the initial diagnosis was established during the first year of life and in five out of twelve (41.7%) patients the first symptoms were observed at birth. RCM was present in all patients, often in combination with septal defects. No ventricular arrhythmias were noted in any of the patients presented here. Myopathy was confirmed by neurological examination, electromyography, and morphological studies. Arthrogryposes was diagnosed in six patients and remained clinically meaningful with increasing age in three of them. One patient underwent successful heart transplantation at the age of 18 years and two patients are currently included in the waiting list for heart transplantation. Two died due to congestive heart failure. One patient had ICD instally as primary prevention of SCD. In ten out of twelve patients the disease was associated with missense variants and only in two cases loss of function variants were detected. In half of the described cases, an amino acid substitution A1186V, altering the structure of IgFLNc10, was found. CONCLUSIONS: The present description of twelve cases of early-onset restrictive cardiomyopathy with congenital myopathy and FLNC mutation, underlines a distinct unique phenotype that can be suggested as a separate clinical form of filaminopathies. Amino acid substitution A1186V, which was observed in half of the cases, defines a mutational hotspot for the reported combination of myopathy and cardiomyopathy. Several independent molecular mechanisms of FLNC mutations linked to filamin structure and function can explain the broad spectrum of FLNC-associated phenotypes. Early disease presentation and unfavorable prognosis of heart failure demanding heart transplantation make awareness of this clinical form of filaminopathy of great clinical importance.

Almazov National Medical Research Centre St Petersburg Russia 197341

Department of Biology and Medical Genetics 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Department of Women's and Children's Health Center for Molecular Medicine Karolinska Institute 17176 Stockholm Sweden

Zobrazit více v PubMed

Ader F, et al. FLNC pathogenic variants in patients with cardiomyopathies: prevalence and genotype-phenotype correlations. Clin Genet. 2019;96:317–329. doi: 10.1111/cge.13594. PubMed DOI

Akhtar MM, et al. Association of left ventricular systolic dysfunction among carriers of truncating variants in Filamin C with frequent ventricular arrhythmia and end-stage heart failure. JAMA Cardiol. 2021;6:891–901. doi: 10.1001/jamacardio.2021.1106. PubMed DOI PMC

Avila-Smirnow D, et al. Cardiac arrhythmia and late-onset muscle weakness caused by a myofibrillar myopathy with unusual histopathological features due to a novel missense mutation in FLNC. Rev Neurol (Paris) 2016;172:594–606. doi: 10.1016/j.neurol.2016.07.017. PubMed DOI

Bains S, et al. A novel truncating variant in FLNC-encoded Filamin C may serve as a proarrhythmic genetic substrate for arrhythmogenic bileaflet mitral valve prolapse syndrome. Mayo Clin Proc. 2019;94:906–913. doi: 10.1016/j.mayocp.2018.11.028. PubMed DOI

Batonnet-Pichon S, et al. Myofibrillar myopathies: new perspectives from animal models to potential therapeutic approaches. J Neuromuscul Dis. 2017;4:1–15. doi: 10.3233/JND-160203. PubMed DOI PMC

Begay RL, et al. Filamin C truncation mutations are associated with arrhythmogenic dilated cardiomyopathy and changes in the cell-cell adhesion structures. JACC Clin Electrophysiol. 2018;4:504–514. doi: 10.1016/j.jacep.2017.12.003. PubMed DOI PMC

Begay RL, et al. FLNC gene splice mutations cause dilated cardiomyopathy. JACC Basic Transl Sci. 2016;1:344–359. doi: 10.1016/j.jacbts.2016.05.004. PubMed DOI PMC

Brodehl A, et al. Mutations in FLNC are associated with familial restrictive cardiomyopathy. Hum Mutat. 2016;37:269–279. doi: 10.1002/humu.22942. PubMed DOI

Carvalho AAS, et al. Genetic mutations and demographic, clinical, and morphological aspects of myofibrillar myopathy in a French cohort. Genet Test Mol Biomarkers. 2018;22:374–383. doi: 10.1089/gtmb.2018.0004. PubMed DOI

Critchley DR, et al. Talin at a glance. J Cell Sci. 2008;121:1345–1347. doi: 10.1242/jcs.018085. PubMed DOI

Culic V, et al. Distal arthrogryposis with variable clinical expression caused by TNNI2 mutation. Hum Genome Var. 2016;3:16035. doi: 10.1038/hgv.2016.35. PubMed DOI PMC

Delort F, et al. Alterations of redox dynamics and desmin post-translational modifications in skeletal muscle models of desminopathies. Exp Cell Res. 2019;383:111539. doi: 10.1016/j.yexcr.2019.111539. PubMed DOI

Deng H, et al. Exome sequencing of a pedigree reveals S339L mutation in the TLN2 gene as a cause of fifth finger camptodactyly. PLoS ONE. 2016;11:e0155180. doi: 10.1371/journal.pone.0155180. PubMed DOI PMC

Duan BC, et al. Alternating hemiplegia and paroxysmal torticollis caused by SCN4A mutation: a new phenotype? Neurology. 2019;93:673–674. doi: 10.1212/WNL.0000000000008212. PubMed DOI

Duff RM, et al. Mutations in the N-terminal actin-binding domain of filamin C cause a distal myopathy. Am J Hum Genet. 2011;88:729–740. doi: 10.1016/j.ajhg.2011.04.021. PubMed DOI PMC

Eden M, et al. Cardiac filaminopathies: illuminating the divergent role of Filamin C mutations in human cardiomyopathy. J Clin Med. 2021 doi: 10.3390/jcm10040577. PubMed DOI PMC

Evangelista T, et al. A heterozygous mutation in the Filamin C gene causes an unusual nemaline myopathy with ring fibers. J Neuropathol Exp Neurol. 2020;79:908–914. doi: 10.1093/jnen/nlaa052. PubMed DOI

Furst DO, et al. ilamin C-related myopathies: pathology and mechanisms. Acta Neuropathol. 2013;125:33–46. doi: 10.1007/s00401-012-1054-9. PubMed DOI PMC

Guergueltcheva V, et al. Distal myopathy with upper limb predominance caused by filamin C haploinsufficiency. Neurology. 2011;77:2105–2114. doi: 10.1212/WNL.0b013e31823dc51e. PubMed DOI

Hall CL, et al. Filamin C variants are associated with a distinctive clinical and immunohistochemical arrhythmogenic cardiomyopathy phenotype. Int J Cardiol. 2020;307:101–108. doi: 10.1016/j.ijcard.2019.09.048. PubMed DOI

Jin JY, et al. The novel compound heterozygous mutations of ECEL1 identified in a family with distal arthrogryposis type 5D. Biomed Res Int. 2020;2020:2149342. doi: 10.1155/2020/2149342. PubMed DOI PMC

Jorholt J, et al. Two new cases of hypertrophic cardiomyopathy and skeletal muscle features associated with ALPK3 homozygous and compound heterozygous variants. Genes (Basel) 2020 doi: 10.3390/genes11101201. PubMed DOI PMC

Kiema T, et al. The molecular basis of filamin binding to integrins and competition with talin. Mol Cell. 2006;21:337–347. doi: 10.1016/j.molcel.2006.01.011. PubMed DOI

Kiselev A, et al. De novo mutations in FLNC leading to early-onset restrictive cardiomyopathy and congenital myopathy. Hum Mutat. 2018 doi: 10.1002/humu.23559. PubMed DOI

Kley RA, et al. Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients. Brain. 2007;130:3250–3264. doi: 10.1093/brain/awm271. PubMed DOI

Kley RA, et al. FLNC-associated myofibrillar myopathy: new clinical, functional, and proteomic data. Neurol Genet. 2021;7:e590. doi: 10.1212/NXG.0000000000000590. PubMed DOI PMC

Kolbel H, et al. First clinical and myopathological description of a myofibrillar myopathy with congenital onset and homozygous mutation in FLNC. Hum Mutat. 2020;41:1600–1614. doi: 10.1002/humu.24062. PubMed DOI

Lad Y, et al. Structure of three tandem filamin domains reveals auto-inhibition of ligand binding. EMBO J. 2007;26:3993–4004. doi: 10.1038/sj.emboj.7601827. PubMed DOI PMC

Luan X, et al. A novel heterozygous deletion-insertion mutation (2695–2712 del/GTTTGT ins) in exon 18 of the filamin C gene causes filaminopathy in a large Chinese family. Neuromuscul Disord. 2010;20:390–396. doi: 10.1016/j.nmd.2010.03.009. PubMed DOI

Mao Z, et al. Structure and function of Filamin C in the muscle Z-disc. Int J Mol Sci. 2020 doi: 10.3390/ijms21082696. PubMed DOI PMC

Miltgen M, et al. Novel heterozygous mutation in ANO3 responsible for craniocervical dystonia. Mov Disord. 2016;31:1251–1252. doi: 10.1002/mds.26717. PubMed DOI

O'Grady GL, et al. Variants in the oxidoreductase PYROXD1 cause early-onset myopathy with internalized nuclei and myofibrillar disorganization. Am J Hum Genet. 2016;99:1086–1105. doi: 10.1016/j.ajhg.2016.09.005. PubMed DOI PMC

Ortiz-Genga MF, et al. Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies. J Am Coll Cardiol. 2016;68:2440–2451. doi: 10.1016/j.jacc.2016.09.927. PubMed DOI

Pires DEV, et al. DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach. Nucleic Acids Res. 2014;42:W314–W319. doi: 10.1093/nar/gku411. PubMed DOI PMC

Previtali SC, et al. Expanding the central nervous system disease spectrum associated with FLNC mutation. Muscle Nerve. 2019;59:E33–E37. doi: 10.1002/mus.26443. PubMed DOI

Richards S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424. doi: 10.1038/gim.2015.30. PubMed DOI PMC

Rojnueangnit K, et al. Identification of gene mutations in primary pediatric cardiomyopathy by whole exome sequencing. Pediatr Cardiol. 2020;41:165–174. doi: 10.1007/s00246-019-02240-x. PubMed DOI

Roldan-Sevilla A, et al. Missense mutations in the FLNC gene causing familial restrictive cardiomyopathy. Circ Genom Precis Med. 2019;12:e002388. doi: 10.1161/CIRCGEN.118.002388. PubMed DOI

Rossi D, et al. A novel FLNC frameshift and an OBSCN variant in a family with distal muscular dystrophy. PLoS ONE. 2017;12:e0186642. doi: 10.1371/journal.pone.0186642. PubMed DOI PMC

Ruparelia AA, et al. Metformin rescues muscle function in BAG3 myofibrillar myopathy models. Autophagy. 2021;17:2494–2510. doi: 10.1080/15548627.2020.1833500. PubMed DOI PMC

Russo LM, et al. Idiopathic restrictive cardiomyopathy in children. Heart. 2005;91:1199–1202. doi: 10.1136/hrt.2004.043869. PubMed DOI PMC

Sammani A, et al. Predicting sustained ventricular arrhythmias in dilated cardiomyopathy: a meta-analysis and systematic review. ESC Heart Fail. 2020;7:1430–1441. doi: 10.1002/ehf2.12689. PubMed DOI PMC

Schanzer A, et al. The p.Ala2430Val mutation in filamin C causes a "hypertrophic myofibrillar cardiomyopathy". J Muscle Res Cell Motil. 2021;42:381–397. doi: 10.1007/s10974-021-09601-1. PubMed DOI

Schubert J, et al. Novel pathogenic variants in filamin C identified in pediatric restrictive cardiomyopathy. Hum Mutat. 2018;39:2083–2096. doi: 10.1002/humu.23661. PubMed DOI

Sethi R, et al. A novel structural unit in the N-terminal region of filamins. J Biol Chem. 2014;289:8588–8598. doi: 10.1074/jbc.M113.537456. PubMed DOI PMC

Shatunov A, et al. In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy. Eur J Hum Genet. 2009;17:656–663. doi: 10.1038/ejhg.2008.226. PubMed DOI PMC

Sievers F, et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. 2011;7:539. doi: 10.1038/msb.2011.75. PubMed DOI PMC

Sjekloća L, et al. Crystal structure of human Filamin C domain 23 and small angle scattering model for filamin C 23–24 dimer. J Mol Biol. 2007;368:1011–1023. doi: 10.1016/j.jmb.2007.02.018. PubMed DOI

Smith DK, et al. Sequence profiles of immunoglobulin and immunoglobulin-like domains. J Mol Biol. 1997;274:530–545. doi: 10.1006/jmbi.1997.1432. PubMed DOI

Tasca G, et al. Novel FLNC mutation in a patient with myofibrillar myopathy in combination with late-onset cerebellar ataxia. Muscle Nerve. 2012;46:275–282. doi: 10.1002/mus.23349. PubMed DOI PMC

Theis JL, et al. Genetic association between hypoplastic left heart syndrome and cardiomyopathies. Circ Genom Precis Med. 2021;14:e003126. doi: 10.1161/CIRCGEN.120.003126. PubMed DOI

Tucker NR, et al. Novel mutation in FLNC (Filamin C) causes familial restrictive cardiomyopathy. Circ Cardiovasc Genet. 2017;10:50. doi: 10.1161/CIRCGENETICS.117.001780. PubMed DOI PMC

Valdes-Mas R, et al. Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy. Nat Commun. 2014;5:5326. doi: 10.1038/ncomms6326. PubMed DOI

van den Bogaart FJ, et al. Widening the spectrum of filamin-C myopathy: predominantly proximal myopathy due to the p.A193T mutation in the actin-binding domain of FLNC. Neuromuscul Disord. 2017;27:73–77. doi: 10.1016/j.nmd.2016.09.017. PubMed DOI

Verdonschot JAJ, et al. A mutation update for the FLNC gene in myopathies and cardiomyopathies. Hum Mutat. 2020;41:1091–1111. doi: 10.1002/humu.24004. PubMed DOI PMC

Vorgerd M, et al. A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy. Am J Hum Genet. 2005;77:297–304. doi: 10.1086/431959. PubMed DOI PMC

Wang WB, et al. Identification of a novel pathogenic mutation of the MYH3 gene in a family with distal arthrogryposis type 2B. Mol Med Rep. 2020;21:438–444. doi: 10.3892/mmr.2019.10820. PubMed DOI

Waterhouse A, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46:W296–W303. doi: 10.1093/nar/gky427. PubMed DOI PMC

Waterhouse AM, et al. Jalview Version 2—a multiple sequence alignment editor and analysis workbench. Bioinformatics. 2009;25:1189–1191. doi: 10.1093/bioinformatics/btp033. PubMed DOI PMC

Webber SA, et al. Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: a report from the Pediatric Cardiomyopathy Registry. Circulation. 2012;126:1237–1244. doi: 10.1161/CIRCULATIONAHA.112.104638. PubMed DOI

Xiao F, et al. Clinical exome sequencing revealed that FLNC variants contribute to the early diagnosis of cardiomyopathies in infant patients. Transl Pediatr. 2020;9:21–33. doi: 10.21037/tp.2019.12.02. PubMed DOI PMC

Zenagui R, et al. A reliable targeted next-generation sequencing strategy for diagnosis of myopathies and muscular dystrophies, especially for the giant titin and nebulin genes. J Mol Diagn. 2018;20:533–549. doi: 10.1016/j.jmoldx.2018.04.001. PubMed DOI

Vershinina T, et al. Features of the clinical phenotype of filamine cardiomyopathies with a debut in early childhood. Pediatria. 2020 doi: 10.24110/0031-403X-2020-99-3-88-95. DOI